BRILINTA PACKAGE INSERT PDF
BRILINTA can lead to fewer CV events for STEMI patients compared to clopidogrel, allowing a growing support for BRILINTA® (ticagrelor) [package insert]. Find out about the BRILINTA® (ticagrelor) mechanism of action. BRILINTA is the first-and-only ;(3) BRILINTA® (ticagrelor) [package insert]. Patient Information Leaflet. Package leaflet: Information for the user. Brilique 90 mg film-coated tablets ticagrelor. Read all of this leaflet carefully before you start .
|Published (Last):||8 July 2018|
|PDF File Size:||6.23 Mb|
|ePub File Size:||11.13 Mb|
|Price:||Free* [*Free Regsitration Required]|
You may report side effects related to AstraZeneca products by clicking here. Plavix should be administered in conjunction with aspirin. Strong inducers substantially reduce ticagrelor exposure and so decrease the efficacy of brlinta As with other oral P2Y 12 inhibitors, co-administration of opioid agonists delay and reduce the absorption of ticagrelor.
You may report side effects related to AstraZeneca products by clicking here.
I recently had a heart attack, but I am not a victim. People who are treated with a stent, and stop taking BRILINTA too soon, have a higher risk of getting a blood clot in the stent, having a heart attack, or pwckage. These can be fatal. Subject to eligibility rules ; restrictions apply.
Bradyarrhythmias including AV block have been reported in the post-marketing setting. For complete information on changes to the Plavix PI, go to www. Do not take new medicines that contain aspirin. Instances of serious bleeding, such as internal bleeding, may require blood transfusions or surgery. Nrilinta is used with aspirin to lower your chance of having another serious problem with your heart or blood vessels such as heart attack, stroke, or blood clots in your stent if you received one.
BRILINTA MECHANISM OF ACTION
Tell your doctor insedt all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Tell your doctor if you take other medicines that contain aspirin. The optimal duration of Plavix therapy is unknown. Your doctor can decide what treatment is needed. Strong inhibitors substantially increase ticagrelor exposure and so increase the risk of adverse events.
Plavix is indicated to reduce the rate of myocardial infarction and stroke For in patients with acute ST-elevation myocardial infarction STEMI who are to be managed medically. Plavix has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re infarction, or stroke.
Plavix is a registered trademark of sanofi-aventis.
BRILINTA and ACS – BRILINTA® (ticagrelor) tablets | For HCPs
Administer 90 mg twice daily during the first year after an ACS event. After one year administer 60 mg twice daily.
For at least the first 12 months following ACS, it is superior to clopidogrel. Plavix has been shown to decrease the rate of a combined endpoint of cardiovascular death, myocardial infarction MIor stroke as well as the rate of a combined endpoint of cardiovascular death, MI, stroke, or refractory ischemia. Bleeding will also take longer than usual to btilinta.
Call your doctor if you have new or unexpected shortness of breath or any side effect that bothers you or that does not go away. The benefit for patients who undergo primary percutaneous coronary intervention is unknown.